Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/26/2008

Ended December 31, December 31,

2006 2007 2006 2007

Aldurazyme (as reported by

BioMarin/Genzyme LLC) (1) $26.5 $35.4 96.3 $123.7

Naglazyme 16.3 25.5 46.5 86.2

Kuvan -- 0.4 -- 0.4

(1) The Company recognizes its 50% share of the net income of

BioMarin/Genzyme LLC as Equity in the income of BioMarin/Genzyme LLC

in the Company's consolidated statements of operations.

BIOMARIN PHARMACEUTICAL INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three Months and Years Ended December 31, 2006 and 2007

(In thousands, except for per share data, unaudited)

Three Months Ended Year Ended

December 31, December 31,

2006 2007 2006 2007

Revenues:

Net product sales $16,310 $26,202 $49,606 $86,802

Collaborative

agreement revenues 4,882 17,506 18,740 28,264

Royalty and license

revenues 827 1,146 15,863 6,515

Total revenues 22,019 44,854 84,209 121,581

Operating expenses:

Cost of sales (1) 3,616 5,224 8,740 18,359

Research and

development (1) 20,572 24,015 66,735 78,600

Selling, general and

administrative (1) 13,719 23,891 48,507 77,539

Amortization of

acquired intangible

assets 1,093 1,093 3,651 4,371

Total operating

expenses 39
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The laboratory information management systems market is ... of technological advancements due to factors such as rising ... integrate healthcare systems, and increasing government support for adoption ... Key players in the market focus on technological advancements ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
(Date:1/22/2015)... 2015   Cypher Genomics, Inc., the leading ... SQNM ), the leading molecular diagnostics company, ... noninvasive prenatal tests (NIPT). Through this agreement, Sequenom ... to advance analysis of clinically-relevant fetal sub-chromosomal variants ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... atoms thick in which electrons appear to be guided ... of travel has been discovered by a team of ... computational models, the team has found that the electrons ... insulating sheets of titanium dioxide exhibit one set of ...
... May 5 On Thursday, May 7, 2009, at 8:30 a.m. Eastern/2:30 ... and MTA: CTIC) management team will host a conference call to discuss ... Conference Call Numbers, ... 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time, ...
... DigEx Solution offers completely interactive gene-level database to ... runs.WESTBOROUGH, Mass., May 5 GenomeQuest, Inc., the ... it has released a Digital Gene Expression Workflow ... data. The Digital Gene Expression Workflow is the ...
Cached Biology Technology:Nano-sandwich triggers novel electron behavior 2Nano-sandwich triggers novel electron behavior 3Cell Therapeutics, Inc. (CTI) to Report 2009 First Quarter Financial Results on May 7 2GenomeQuest, Inc. Announces Digital Gene Expression Solution Within Its Sequence Data Management Platform 2
(Date:1/22/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the recent success of the Wocket™ smart wallet at CES 2015 ... wallet was named as one of the "11 Hot Products at CES" ... Launched At CES So Far" by Newseveryday.com and "The top 10 gadgets ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... of the "Global Wearable Technologies Market and ... Overview, Trends and Forecast 2014-2020" report to ... are smart devices that can be worn on ...
(Date:12/22/2014)... Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce market, ... Apollo Robbins for the 2015 International CES debut ... Apollo Robbins will be at the NXT-ID booth January ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
... working together to meet the challenges of climate change. Research, ... 28th June will demonstrate innovative techniques and insights into ways ... and diminishing fish stocks. , In seven out of ... most important crops has fallen short of demand, leading to ...
... terrorist attacks, the prospect of a rogue nation using nuclear ... fostering efforts to develop a new family of drugs that ... in the current edition of Chemical & Engineering News ... the world,s largest scientific society. Ann M. Thayer, C&EN ...
... toward treating disease with minute capsules containing not drugs ... making the drug. In an article in ACS, journal ... nano-sized capsules that contain the genetically coded instructions, plus ... that can be switched on with an external signal. ...
Cached Biology News: